“Summary  Life expectancy for haemophilia has increased s


“Summary.  Life expectancy for haemophilia has increased significantly in many countries. selleckchem This represents a major success

of the improved safety of therapeutic materials to treat haemophilia and of improved quality of care. This improved longevity will generate a population of older individuals with haemophilia with complex medical problems associated with age and managing such clinical issues is likely to be challenging. The world population is ageing in an unprecedented way in part, as a result of a major increase in life expectancy through decreased infant mortality and improvements in healthcare, housing and diet. Globally, the number of older persons is expected to exceed the number of children by 2047, but in developed countries this milestone was passed in 1998. [1] An ageing

population is likely to have wide ranging consequences for the economic and social environment of society and as older individuals have more chronic illness, the impact of a larger population of elderly individuals will be significant for healthcare systems. [1,2] The world population of persons with haemophilia (pwh) is also likely to have benefited from the general factors contributing to health improvement but have also benefited more specifically from advances in haemophilia care such as the availability find more of safe, effective factor concentrate, the development of comprehensive care programmes and therapeutic modalities such as home treatment and prophylaxis. There is clear evidence that life expectancy has increased for individuals with haemophilia. In the early part of the last century, the prevalence of haemophilia was estimated to be only 4 per 100 000 males while the prevalence in the 1990s was 13–18 per 100 000 [3]. More recent studies estimating life expectancy

for individuals with severe haemophilia not infected click here with HIV in the period 1977–2001 have ranged from 63 years for the UK, to 70 years (Netherlands) and 73 years (Canada). [4–6] However, because improvements in haemophilia care have been relatively recent and the high mortality rate from bleeding and transfusion transmitted infection, particularly HIV in past decades, there is, at present, in many countries, a relatively small population of severely affected individuals with haemophilia at advanced age and thus, relatively little experience in managing age-related medical problems in this group of individuals. As much as 88% of the general population over the age of 65 years have one or more chronic medical condition [7] and for the first time, many countries have seen the emergence of a significant middle aged and elderly population of persons with haemophilia.

Comments are closed.